Drug intelligence / Profile preview

Bawei Lidan Granules

Development stage
Unknown
Lead developer
Jilin Academy of Chinese Medicine Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Bawei Lidan Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Jilin Province Academy of Traditional Chinese Medicine for the treatment of hepatobiliary conditions. It is primarily indicated for chronic cholecystitis and gallstones (cholelithiasis). The formulation is designed to clear damp-heat, promote gallbladder function, and facilitate the expulsion of stones according to TCM principles. Its pharmacological effects include increasing bile secretion (choleretic effect), enhancing gallbladder contraction, and providing anti-inflammatory and analgesic relief in the biliary tract. The "eight flavors" in its name refer to its constituent herbal ingredients, which typically include *Artemisia capillaris*, *Curcuma wenyujin*, and *Rheum palmatum*, among others. It is administered orally as granules and is a registered pharmaceutical product in China.

Brand names
Bawei Lidan Granules
Other names
八味利胆颗粒Bawei Lidan Keli
02

Targets

ABCB11 (Bile salt export pump)CCKAR (Cholecystokinin A receptor)

Beyond the preview

Go deeper on Bawei Lidan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bawei Lidan Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call